<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35547223</PMID><DateRevised><Year>2022</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Molecular Epidemiology of Herpangina Children in Tongzhou District, Beijing, China, During 2019-2020.</ArticleTitle><Pagination><StartPage>822796</StartPage><MedlinePgn>822796</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">822796</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2022.822796</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The changing pattern of pathogen spectrum causing herpangina in the time of coronavirus disease 2019 (COVID-19) pandemic was unknown. The purpose of this study was to investigate the changes on the molecular epidemiology of herpangina children during 2019-2020 in Tongzhou district, Beijing, China.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">From January 2019 to December 2020, children diagnosed with herpangina were recruited by the staff from Tongzhou Center for Disease Control and Prevention (CDC) in Beijing. Viral RNA extraction from pharyngeal swabs was used for enterovirus (EV) detection and the complete VP1 gene was sequenced. The phylogenetic analysis was performed based on all VP1 sequences for EV genotypes.</AbstractText><AbstractText Label="RESULT" NlmCategory="UNASSIGNED">A total of 1,331 herpangina children were identified during 2019-2020 with 1,121 in 2019 and 210 in 2020, respectively. The predominant epidemic peak of herpangina children was in summer and autumn of 2019, but not observed in 2020. Compared to the number of herpangina children reported in 2019, it decreased sharply in 2020. Among 129 samples tested in 2019, 61 (47.3%) children were detected with EV, while 22.5% (20/89) were positive in 2020. The positive rate for EV increased since June 2019, peaked at August 2019, and decreased continuously until February 2020. No cases were observed from February to July in 2020, and the positive rate of EV rebounded to previous level since August 2020. Four genotypes, including coxsackievirus A6 (CV-A6, 9.3%), CV-A4 (7.8%), CV-A10 (2.3%) and CV-A16 (10.1%), were identified in 2019, and only three genotypes, including CV-A6 (9.0%), CV-A10 (6.7%) and CV-A16 (1.1%), were identified in 2020. The phylogenetic analysis showed that all CV-A6 strains from Tongzhou located in Group C, and the predominant strains mainly located in C2-C4 subgroups during 2016-2018 and changed into C1 subgroup during 2018-2020. CV-A16 strains mainly located in Group B, which consisting of strains widely distributed around the world.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The predominant genotypes gradually shifted from CV-A16, CV-A4 and CV-A6 in 2019 to CV-A6 in 2020 under COVID-19 pandemic. Genotype-based surveillance will provide robust evidence and facilitate the development of public health measures.</AbstractText><CopyrightInformation>Copyright © 2022 Xie, Chen, Yang, Cui, Zhang, Zhao, Zhang, Du, Cui and Lu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Ming-Zhu</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lin-Yi</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yan-Na</ForeName><Initials>YN</Initials><AffiliationInfo><Affiliation>Institute for Infectious Diseases and Endemic Diseases Prevention and Control, Beijing Tongzhou Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Infectious Diseases and Endemic Diseases Prevention and Control, Beijing Tongzhou Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Si-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Tian-Shuo</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wan-Xue</ForeName><Initials>WX</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Fu-Qiang</ForeName><Initials>FQ</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qing-Bin</ForeName><Initials>QB</Initials><AffiliationInfo><Affiliation>Department of Laboratorial Science and Technology and Vaccine Research Center, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">herpangina</Keyword><Keyword MajorTopicYN="N">molecular epidemiology</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35547223</ArticleId><ArticleId IdType="pmc">PMC9082675</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.822796</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corsino CB, Ali R, Linklater DR. Herpangina. Treasure Island, FL: StatPearls Publishing; (2021). p. 1–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29939569</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Li XW, Liu QB, Deng HL, Liu G, Jiang RM, et al. . Diagnosis and treatment of herpangina: Chinese expert consensus. World J Pediatr. (2020) 16:129–34. 10.1007/s12519-019-00277-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00277-9</ArticleId><ArticleId IdType="pubmed">31347021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics. (2007) 120:e244–52. 10.1542/peds.2006-3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-3331</ArticleId><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao TS, Du J, Liu HY, Liu YQ, Cui FQ, Lu QB. Research progress in epidemiology and etiology of herpangina. Chin J Viral Dis. (2020) 10:385–90. 10.16505/j.2095-0136.2020.0022</Citation><ArticleIdList><ArticleId IdType="doi">10.16505/j.2095-0136.2020.0022</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao TS, Du J, Li HJ, Cui Y, Liu YQ, Yang YN, et al. . Molecular epidemiology and clinical characteristics of herpangina children in Beijing, China: a surveillance study. PeerJ. (2020) 8:e9991. 10.7717/peerj.9991</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9991</ArticleId><ArticleId IdType="pmc">PMC7568857</ArticleId><ArticleId IdType="pubmed">33088614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunagawa S, Iha Y, Kinjo T, Nakamura K, Fujita J. Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Respir Investig. (2021) 59:149–52. 10.1016/j.resinv.2020.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7667393</ArticleId><ArticleId IdType="pubmed">33246913</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Wang J, Lv H, Lu H. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza. Biosci Trends. (2021) 15:192–5. 10.5582/bst.2021.01242</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2021.01242</ArticleId><ArticleId IdType="pubmed">34176827</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. . Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. MMWR. (2020) 69:1305–9. 10.15585/mmwr.mm6937a6</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6937a6</ArticleId><ArticleId IdType="pmc">PMC7498167</ArticleId><ArticleId IdType="pubmed">32941415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Xu Y, Zhu Y, Tang F. Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China. Hum Vaccin Immunother. (2021) 10:1–7. 10.1080/21645515.2021.1956227</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1956227</ArticleId><ArticleId IdType="pmc">PMC8828147</ArticleId><ArticleId IdType="pubmed">34374635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. (1999) 41:95–8.</Citation></Reference><Reference><Citation>Li W, Gao HH, Zhang Q, Liu YJ, Tao R, Cheng YP, et al. . Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou, China. Sci Rep. (2016) 6:35388. 10.1038/srep35388</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35388</ArticleId><ArticleId IdType="pmc">PMC5067559</ArticleId><ArticleId IdType="pubmed">27752104</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng HR, Zheng HY, Liu L, Lu J, Tan XH, Sun LM, et al. . Etiological characteristics of herpangina cases in Guangzhou city in Guangdong province, 2015. Chin J Exp Clin Virol. (2018) 32:48–50. 10.3760/cma.j.issn.1003-9279.2017.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.1003-9279.2017.05.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JY, Xiao Z, Cui HY. Investigation of two outbreaks of herpangina caused by CoxA4 in kindergartens. Chin J Sch Health. (2015) 36:631–2. 10.16835/j.cnki.1000-9817.2015.04.056</Citation><ArticleIdList><ArticleId IdType="doi">10.16835/j.cnki.1000-9817.2015.04.056</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Yang JY, Dong XG, Yang XX, Yu H, Li RX, et al. . Investigation of two Coxsackievirus A10 caused herpangina outbreaks in child care settings in Fengtai, Beijing. Dis Surveill. (2017) 32:168–70. 10.3784/j.issn.1003-9661.2017.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.3784/j.issn.1003-9661.2017.02.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand A, le Sage FV, Pereira B, Cohen R, Levy C, Archimbaud C, et al. . Ambulatory pediatric surveillance of hand, foot and mouth disease as signal of an outbreak of coxsackievirus A6 infections, France, 2014-2015. Emerg Infect Dis. (2016) 22:1884–93. 10.3201/eid2211.160590</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2211.160590</ArticleId><ArticleId IdType="pmc">PMC5088007</ArticleId><ArticleId IdType="pubmed">27767012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai YH, Zhang WW, Wu J, Zhang JZ, Shen MJ, Yao SF, et al. . Molecular epidemiology and clinical features of enteroviruses-associated hand, foot, and mouth disease and herpangina outbreak in Zunyi, China, 2019. Front Med. (2021) 8:656699. 10.3389/fmed.2021.656699</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.656699</ArticleId><ArticleId IdType="pmc">PMC8109248</ArticleId><ArticleId IdType="pubmed">33981716</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Q, Xie MY, Zhang YH, Liu Q, Li WR, Li SP, et al. . Molecular epidemiology of the enteroviruses associated with hand, foot and mouth disease/herpangina in Dongguan, China, 2015. Arch Virol. (2016) 161:3463–71. 10.1007/s00705-016-3058-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3058-6</ArticleId><ArticleId IdType="pubmed">27654666</ArticleId></ArticleIdList></Reference><Reference><Citation>Min N, Ong YHB, Han AX, Ho SX, Yen EWP, Ban KHK, et al. . An epidemiological surveillance of hand foot and mouth disease in paediatric patients and in community: a Singapore retrospective cohort study, 2013-2018. PLoS Neglected Trop Dis. (2021) 15:e0008885. 10.1371/journal.pntd.0008885</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008885</ArticleId><ArticleId IdType="pmc">PMC7901731</ArticleId><ArticleId IdType="pubmed">33566802</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Jia LP, Yu FY, Liu LY, Song QW, Dong HJ, et al. . Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019. World J Pediatr. (2021) 17:508–16. 10.1007/s12519-021-00451-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00451-y</ArticleId><ArticleId IdType="pmc">PMC8523403</ArticleId><ArticleId IdType="pubmed">34453285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanbayashi D, Kaida A, Yamamoto SP, Hirai Y, Kubo H, Fujimori R, et al. . Impact of Coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan. J Med Virol. (2017) 89:2116–21. 10.1002/jmv.24905</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24905</ArticleId><ArticleId IdType="pubmed">28771766</ArticleId></ArticleIdList></Reference><Reference><Citation>Thammasonthijarern N, Kosoltanapiwat N, Nuprasert W, Sittikul P, Sriburin P, Pan-Ngum W, et al. . Molecular epidemiological study of hand, foot, and mouth disease in a kindergarten-based setting in Bangkok, Thailand. Pathogens. (2021) 10:576. 10.3390/pathogens10050576</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050576</ArticleId><ArticleId IdType="pmc">PMC8150733</ArticleId><ArticleId IdType="pubmed">34068676</ArticleId></ArticleIdList></Reference><Reference><Citation>He SZ, Chen MY, Xu XR, Yan Q, Niu JJ, Wu WH, et al. . Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015. Epidemiol Infect. (2017) 145:1865–74. 10.1017/S0950268817000309</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268817000309</ArticleId><ArticleId IdType="pmc">PMC9203317</ArticleId><ArticleId IdType="pubmed">28367766</ArticleId></ArticleIdList></Reference><Reference><Citation>The People's Government of Beijing Municipality website.  (2020). Available online at: http://www.beijing.gov.cn/gongkai/ldhd/202007/t20200721_1953428.html (accessed February 20, 2022).</Citation></Reference><Reference><Citation>He SZ, Chen MY, Wu WH, Yan Q, Zhuo ZH, Su XS, et al. . An emerging and expanding clade accounts for the persistent outbreak of Coxsackievirus A6-associated hand, foot, and mouth disease in China since 2013. Virology. (2018) 518:328–34. 10.1016/j.virol.2018.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.03.012</ArticleId><ArticleId IdType="pubmed">29587191</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MY, He SZ, Yan Q, Xu XR, Wu WH, Ge SX, et al. . Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015. J Clin Virol. (2017) 93:20–4. 10.1016/j.jcv.2017.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.011</ArticleId><ArticleId IdType="pubmed">28577423</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Cui DW, Wang L, Cheng J, Sun CG, Li LJ, et al. . Genetic characteristics of the P1 coding region of coxsackievirus A16 associated with hand, foot, and mouth disease in China. Mol Biol Rep. (2018) 45:1947–55. 10.1007/s11033-018-4345-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-018-4345-y</ArticleId><ArticleId IdType="pubmed">30182173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>